Other News to Note
Mezzion Pharma Co. Ltd., of Seoul, South Korea, said it signed a deal with New England Research Institutes Inc., which is authorized by the National Heart, Lung and Blood Institute (NHLBI)-supported Pediatric Heart Network to manage and conduct clinical trials.
To continue reading subscribe now to BioWorld Asia (formerly International)
Learn More about BioWorld Asia (formerly International)
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.